Literature DB >> 11205929

Primary pulmonary hypertension in HIV patients: a systematic review.

A M Pellicelli1, G Barbaro, F Palmieri, E Girardi, C D'Ambrosio, A Rianda, G Barbarini, D Frigiotti, M C Borgia, N Petrosillo.   

Abstract

The relationship between grade of pulmonary hypertension and factors associated with human immunodeficiency virus among patients with HIV infection is poorly documented. This report documents the most extensive attempt made thus far to determine whether a relationship exists between degree of pulmonary hypertension and the following conditions: HIV risk factor, degree of immunosuppression, presence or absence of AIDS, and presence or absence of liver cirrhosis. A retrospective study involving a search of the published literature on primary pulmonary hypertension among HIV cases from 1987 to 1998, using the Medline and Aidsline databases was conducted. Patients for whom secondary causes of pulmonary hypertension could be excluded were selected, and the following information for each was recorded: age, gender, risk factors for HIV infection, HIV disease stage according to the Centers for Disease Control, previous opportunistic and neoplastic diseases, CD4+ cell count (cells/L), presence or absence of liver cirrhosis, pulmonary systolic artery pressure level, and lung pathology specimens. Information about the patient's survival time was also recorded. Seventy-six patients were judged to have primary pulmonary hypertension and were included in the study. While no correlation was found between pulmonary systolic artery pressure level and CD4+ cell counts, a statistically significant difference was found between HIV-positive patients with and without AIDS as determined by the Centers for Disease Control criteria with regard to the degree of pulmonary hypertension, expressed as pulmonary systolic artery pressure level (85.4 +/- 17 mm Hg vs 71.8 +/- 15 mm Hg, p < 0.013). Although a higher PAPS was present in HIV cirrhotic patients, a statistically significant difference was not found between degree of pulmonary hypertension and evidence of hepatic cirrhosis (85 +/- 21 mm Hg vs 73.1 +/- 15 mm Hg, p < 0.062). Patients with AIDS and primary pulmonary hypertension present a higher degree of pulmonary hypertension than non-AIDS patients. Pulmonary hypertension associated with HIV seems to be related to a cytokine-related stimulation and proliferation of endothelium. High levels of cytokines present in AIDS patients can favor pulmonary hypertension, but the role of a host response to HIV--determined by one or more HLA subtypes--is suspected to enhance high cytokine production levels.

Entities:  

Mesh:

Year:  2001        PMID: 11205929     DOI: 10.1177/000331970105200105

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  19 in total

Review 1.  Cardiovascular manifestations of HIV infection.

Authors:  G Barbaro
Journal:  J R Soc Med       Date:  2001-08       Impact factor: 5.344

Review 2.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

3.  Contributions of pulmonary hypertension to HIV-related cardiac dysfunction.

Authors:  Godsent C Isiguzo; Basil N Okeahialam; Solomon S Danbauchi; Augustine N Odili; Michael O Iroezindu; Ugoagwu Placid
Journal:  Indian Heart J       Date:  2013-09-02

Review 4.  Drug abuse and HIV-related pulmonary hypertension: double hit injury.

Authors:  Zachery J Harter; Stuti Agarwal; Pranjali Dalvi; Norbert F Voelkel; Navneet K Dhillon
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

Review 5.  HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease.

Authors:  Revery P Barnes; John Charles A Lacson; Hossein Bahrami
Journal:  Curr Atheroscler Rep       Date:  2017-05       Impact factor: 5.113

6.  Pulmonary hypertension associated with HIV infection: pulmonary vascular disease: the global perspective.

Authors:  Sharilyn Almodovar; Stefania Cicalini; Nicola Petrosillo; Sonia C Flores
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

Review 7.  Current update on HIV-associated vascular disease and endothelial dysfunction.

Authors:  Hong Mu; Hong Chai; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

8.  Non-congenital heart disease associated pediatric pulmonary arterial hypertension.

Authors:  D D Ivy; J A Feinstein; T Humpl; E B Rosenzweig
Journal:  Prog Pediatr Cardiol       Date:  2009-12-01

Review 9.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

10.  Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension.

Authors:  Priscilla Y Hsue; Steven G Deeks; Husam H Farah; Swapna Palav; Samira Y Ahmed; Amanda Schnell; Allison B Ellman; Laurence Huang; Sheila C Dollard; Jeffrey N Martin
Journal:  AIDS       Date:  2008-04-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.